Tuesday, September 9, 2014

10 Best Safest Stocks To Watch Right Now

BALTIMORE (Stockpickr) - Don't let your guard down. The S&P 500 may be poking holes in new all time highs and the nonsense on Capitol Hill may even be resolved, but that doesn't meant that you should keep hanging onto everything in your portfolio.

That's because even the biggest, "safest" blue-chips could be toxic to your performance in the final quarter of this year.

There's no question that the big indices are still in bull mode, but it's worth noting that the Dow Jones Industrial Average looks materially weaker than the S&P right now. The big names that tend to dominate the Dow are starting to show some cracks -- well, some of them are, anyway.

That's why we're taking a closer look at five "toxic" stocks you should be selling in October. To be fair, the companies I'm talking about today aren't exactly "junk."

By that, I mean they're not next up in line at bankruptcy court. But that's frankly irrelevant; from a technical analysis standpoint, they're some of the worst positioned names out there right now. For that reason, fundamental investors need to decide how long they're willing to take the pain if they want to hold onto these firms this summer. And for investors looking to buy one of these positions, it makes sense to wait for more favorable technical conditions (and a lower share price) before piling in.

Top 5 Telecom Stocks To Watch Right Now: Pacific WebWorks Inc (PWEB)

Pacific WebWorks, Inc. (Pacific WebWorks), incorporated on May 18, 1987, is an application service provider and software development firm that develops business software technologies and services for business merchants and organizations using Internet and other technologies. The Company�� product family provides tools for Website creation, management and maintenance, electronic business storefront hosting and Internet payment systems for the small- to medium-sized business and organization. Its four wholly owned subsidiaries include Intellipay, Inc., TradeWorks Marketing, Inc., FundWorks, Inc and Pacific WebWorks International, LTD.

Visual WebTools Version 4.1 (V4.1)

V4.1 is a suite of software programs that fit together to perform the basic business functions that are effective on the Internet. The products in this suite include WebWizard, ClipOn Commerce, WebContacts, WebChannels, Web Profiling tool, WebStats, Auction Connection and Increase My Margin. WebWizard is a Web page design program that possesses a user interface and templates for the novice, has a functionality for Web design professionals. In 2010, the Company released WebWizard 5 and it incorporates site components like tables, frames, flash and other multimedia capabilities in a straightforward, menu driven process.

The Company�� customers can manage their sites' layout, colors, contents, tables and graphics. WebWizard includes a library of hundreds of graphics that are freely accessible by its customers. WebWizard allows its customers to create, update and modify their Websites. ClipOn Commerce is an e-storefront and product management system, coupled with shopping cart technology. ClipOn Commerce allows the Company�� customers to build an Internet storefront. They can create a product catalog, organize and search products by unlimited categories and import/export to and from their database. ClipOn Commerce is designed to function with a third-party merchant account and is integrated with t! he Company�� Intellipay payment system, which allows its clients to accept all major credit cards online. ClipOn Commerce has support for QuickBooks accounting software enabling the Company�� customers to update between their accounting records and Internet storefront. ClipOn Commerce also features uninterrupted power supply (UPS) shipping integration.

WebContacts is a contact management program. Companies that use the Company�� system can utilize WebContacts to organize information about all the entities they do business with, including customers, suppliers and distributors. WebContacts will also enable them to capture information about people who visit their Website, if those visitors elect to supply contact information at the site. WebChannels is an e-mail distribution program that enables Pacific WebWorks��customers to send customized e-mails in either plaintext or hyper text markup language (HTML) format to their WebContacts database of visitors. By using WebChannels, a client can send out a weekly newsletter, coupons or special offers to an entire customer base, certain visitor types or to a segment of their customers.

Web profiling tool is a form and survey creation tool that helps capture feedback and demographic information from customers and Website visitors. The Company�� clients can create customizable forms, surveys and interactive questionnaires. The Web profiling tool includes a catalog of pre-designed questions, such as education level, hobbies and satisfaction level. The profiling forms may also be custom created by the Company�� customers. WebStats enables the Company�� customers to analyze visitor activities on their Websites in order to track pages viewed, hits and time of access. WebStats is a statistics program that provides detailed reports and graphs related to referring pages, geographic location of visitors, browsers and the operating systems Website visitors are using, what Web pages generate hits and what pages are the most popular. Au! ction Con! nection is a module that allows Visual WebTools users to list inventory items with eBay. Increase My Margin is a tool that allows eBay users to analyze information and data related to the sale of thousands of products sold on eBay over a period of time.

Intellipay Payment System

The Intellipay payment system group of products offers payment technologies for business-to-business and business-to-customer uses on the Internet and in physical store locations. These products allow the Company�� customers to accept real time credit card payments from their Website, Internet appliances, kiosks or at remote locations through their Nextel cell phone or at the physical point of sale. Point-of-sale professionals provide technical support and ePayment professionals help the business locate an Internet-approved merchant account if needed. Once customers enter the necessary data in a secure form, Intellipay processes the transaction in real-time (2 to 5 seconds) and returns the customer back to the business site. Intellipay also provides methods for enterprise-level businesses to link Intellipay products, services and features into their e-commerce Websites and transmit transactional data for use in back office systems.

The Company�� ePayment System supports all major card types, including Visa, MasterCard, American Express, Discover, Diners Club and JCB. It also provides support for Visa and MasterCard debit (check) cards and Level Two corporate/commercial cards through various bank networks. Transaction types include normal authorizations, pre-authorizations intended for delayed settlement, force allowing a transaction authorized offline (possibly a voice authorization) to be settled, credits for refunds, and Intellipay's address verification system (AVS) allows merchants to retrieve a score and verify the account validity. This Intellipay product allows the Company�� customers to control transaction level behavior depending on AVS scores and duplicate transaction attemp! t detecti! on. Intellipay also automatically settles merchant batches nightly so its customers are freed from forcing settlement via manual or programmatic methods. The Intellipay system is transportable meaning that a customer can switch Website hosting companies, move between e-commerce software programs or change to or from many merchant account providers.

ExpertLink is Intellipay's connection protocol for high-volume Internet businesses requiring high velocity real-time transaction authorizations linked to their own secure Website and/or back office systems. ExpertLink is a standards-based secure communications method allowing Web developers and application developers to build in the ePayment processing and various features, including batch management commands, duplicate transaction detection and management. The Company�� customers purchase ExpertLink or LinkSmart, and both come with Smart Terminal and the Secure Account Management System (SAMS).

LinkSmart provides the Company�� online customers with ePayment features with minimal technical installation on their side. With LinkSmart, the Company�� customer does not need to pay for installation and maintenance of secure servers since LinkSmart serves the secure, customizable payment pages for them. LinkSmart offloads mission-critical, e-commerce tasks from the merchant.

Smart Terminal allows Pacific WebWorks��customers to securely log into their Intellipay account from any Internet browser and authorize manual transactions and orders they have received through offline methods. Smart Terminal supports transactions, including normal authorizations, authorization-only for delayed settlement, settlement for non-Intellipay authorized transactions, credits and partial credits. Most clients receive Smart Terminal along with LinkSmart or ExpertLink, but Smart Terminal can also be purchased as a standalone product.

Secure Account Management System (SAMS) allows Intellipay customers to securely log into Intellip! ay's SAMS! from any Web browser to configure and control various Intellipay components and behaviors. Customers can also view transaction histories for any day in the past 180 day period. IntelliPay Desktop Terminal (IDT) brings all of the functionality of a virtual terminal application to the customers��desktop, while supporting hardware, such as a card reader and receipt printer. IntelliPay Wireless Terminal allows a merchant to accept either swiped or keyed transactions using a Nextel Cellular/Data phone using a card reader.

The Company competes with AuthorizeNet and VeriSign.

Advisors' Opinion:
  • [By CRWE]

    Today, PWEB remains (0.00%) +0.000 at $.0185 with 2,891 shares in play thus far (ref. google finance Delayed: 9:34AM EDT July 19, 2013).

    Pacific WebWorks, Inc. previously reported the following business update. For the first six months of 2013 the Company has focused on revitalizing its internet technology business model. As previously reported, Pacific WebWorks has expanded its software suite and established a framework for reaching new markets with its software products. The Company believes there is strong demand for its products and is aggressively pursuing the opportunity to obtain new customers through a variety of marketing methods.

    Lance Bell, CEO, stated, ��e are excited to report a number of accomplishments during the first six months of 2013. We have rounded out our management team, finalized our infrastructure and have begun to market our software products. We are encouraged by the initial results of these efforts.��/p>

  • [By CRWE]

    Today, PWEB remains (0.00%) +0.000 at $.0231 with 1,000 shares in play thus far (ref. google finance Delayed: 9:30AM EDT July 16, 2013).

    Pacific WebWorks, Inc. previously reported the following business update. For the first six months of 2013 the Company has focused on revitalizing its internet technology business model. As previously reported, Pacific WebWorks has expanded its software suite and established a framework for reaching new markets with its software products. The Company believes there is strong demand for its products and is aggressively pursuing the opportunity to obtain new customers through a variety of marketing methods.

    Lance Bell, CEO, stated, ��e are excited to report a number of accomplishments during the first six months of 2013. We have rounded out our management team, finalized our infrastructure and have begun to market our software products. We are encouraged by the initial results of these efforts.��/p>

10 Best Safest Stocks To Watch Right Now: Ishares Msci Australia Inc (EWA)

iShares MSCI Australia Index Fund (the Fund) seeks to provide investment results that correspond generally to the price and yield performance of publicly traded securities in the aggregate in the Australian market, as measured by the MSCI Australia Index (the Index). The Index seeks to measure the performance of the Australian equity market. The Index is a capitalization-weighted index that aims to capture 85% of the (publicly available) total market capitalization. Component companies are adjusted for available float and must meet objective criteria for inclusion in the Index. The Index is reviewed quarterly.

The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. The Fund�� investment advisor is Barclays Global Fund Advisors.

Advisors' Opinion:
  • [By Chad Fraser]

    Another option is to buy units of an Australian exchange traded fund (ETF) like the iShares MSCI Australia Index Fund (NYSE: EWA), one of the investments we cover in Australian Edge’s How They Rate universe, which keeps over 100 Australian companies and other investments under continuous review.

10 Best Safest Stocks To Watch Right Now: Electro Rent Corporation(ELRC)

Electro Rent Corporation engages in the rental, lease, and sale of new and used electronic test and measurement equipment. Its equipment portfolio consists of general purpose test and measurement instruments; personal computers, workstations, and servers; and electrical test equipment and inspection equipment. The company rents or leases its equipment primarily to companies operating in the aerospace, defense, telecommunications, electronics, and semiconductor industries. Electro Rent Corporation serves its customers through sales offices, and calibration and service centers in the United States, Canada, China, and Europe. The company was founded in 1965 and is headquartered in Van Nuys, California.

Advisors' Opinion:
  • [By Lisa Levin]

    Electro Rent (NASDAQ: ELRC) shares fell 0.77% to reach a new 52-week low of $15.39. Electro Rent's trailing-twelve-month profit margin is 9.24%.

    Posted-In: 52-Week LowsNews Movers & Shakers Intraday Update Markets

  • [By Seth Jayson]

    Calling all cash flows
    When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Electro Rent (Nasdaq: ELRC  ) , whose recent revenue and earnings are plotted below.

10 Best Safest Stocks To Watch Right Now: Allot Communications Ltd.(ALLT)

Allot Communications Ltd. engages in developing, selling, and marketing Internet protocol service optimization and revenue generation solutions in Europe, the Middle East, Africa, the Americas, Asia, and Oceania. Its solutions are used to create policies to monitor network applications, enforce quality of service policies that guarantee mission-critical application performance, mitigate security risks, and leverage network infrastructure investments. The company offers traffic management systems, including Service Gateway platform for broadband service control and optimization based on DPI; and NetEnforcer traffic management system that inspects, monitors, and controls network traffic by application and by user. Its network management application suites comprise NetXplorer that provides service providers and enterprise customers a view of traffic on the network; and Subscriber Management Platform, a system that helps service providers build an intelligent service network d esigned to deliver the quality of experience. The company also offers ServiceProtector, which ensures service continuity, and guards network integrity against known and unknown threats, as well as enables surgical mitigation through immediate identification of denial of service attacks, zero day attacks, worms, zombie, and botnets. In addition, it provides MediaSwift that caches and accelerates popular Internet video. The company markets and sells its products to carriers, mobile operators, cable operators, educational institutions, governments, and enterprises, as well as wireless, wireline, and satellite Internet service providers. It sells it products through distributors, resellers, OEMs, value added resellers, and system integrators, as well as through direct sales. The company was formerly known as Ariadne Ltd. and changed its name to Allot Communications Ltd. in September 1997. Allot Communications Ltd. was founded in 1996 and is based in Hod-Hasharon, Israel.

Advisors' Opinion:
  • [By Jon C. Ogg]

    Allot Communications Inc. (NASDAQ: ALLT) was raised to Outperform with an $18 price target at Oppenheimer.

    Baxter International Inc. (NYSE: BAX) was added to the Conviction Buy list with an $86 price target at Goldman Sachs.

  • [By Garrett Cook]

    Telecommunications services shares gained around 0.25 percent in today’s trading. Top gainers in the sector included NQ Mobile (NYSE: NQ), Allot Communications (NASDAQ: ALLT), and SK Telecom Co (NYSE: SKM).

  • [By Garrett Cook]

    Telecommunications services shares gained around 0.25 percent in today’s trading. Top gainers in the sector included NQ Mobile (NYSE: NQ), Allot Communications (NASDAQ: ALLT), and SK Telecom Co (NYSE: SKM).

10 Best Safest Stocks To Watch Right Now: Pharmaxis Ltd (PXS)

Pharmaxis Ltd is a pharmaceutical company that researches, develops and commercializes therapies for undertreated respiratory diseases. Its therapeutic interests include lung diseases such as cystic fibrosis, bronchiectasis and asthma, as well as chronic obstructive pulmonary diseases such as chronic bronchitis and pulmonary fibrosis. The Company�� products include Aridol and Bronchitol. The Company�� Aridol product is a lung function test. The product is designed to identify twitchy or hyper-responsive airways and to assist in diagnosing and managing asthma. Aridol is approved for sale in Australia, European countries, South Korea and the United States. is a drug designed to reduce the amount of mucus build-up in the lungs of patients suffering from chronic respiratory conditions. The Company develops Bronchitol for diseases including cystic fibrosis, bronchiectasis and chronic bronchitis. Advisors' Opinion:
  • [By Trista Kelley]

    Science in Sport Ltd. broke away from its parent company, Provexis Plc (PXS), and began trading today after an initial public offering as the maker of nutritional sports gels rides a surge in Britain�� Lycra-clad cyclists.

10 Best Safest Stocks To Watch Right Now: Edp Energias de Portugal SA (EDPFY.PK)

EDP Energias de Portugal SA (EDP), incorporated in 1976, is a Portugal-based company engaged in the electric energy and gas sectors. The Company develops its activities in the business areas of generation, supply and distribution of electricity and supply and distribution of gas. The Company operates through six business units: Electricity Generation, Renewable Energies, Electricity Distribution, Electricity Supply, Gas and Brazil Operations. EDP is also present in electricity generation, supply and distribution in Brazil, Spain and the United States. In April 2008, the Company acquired EDP Renovaveis through Nuevas Energias de Occidente (NEO). In February 2008, Horizon Wind Energy, LLC, EDP�� 100%-owned subsidiary for United States wind operations, acquired from Hydra Energy, LLC, a portfolio of six early stage projects in an aggregate of 1,050 megawatts of wind capacity, located in the States of Illinois, Indiana and Ohio, the United States.

Electricity Generation

In Spain, EDP operates through HC Energia. Cogeneration consists of simultaneous production of power and steam using thermal technology, such as in the form of natural gas turbines. Cogenerators are usually attached to an industrial customer or services, to which they supply the electricity and steam they need. Energy generation includes a centralised energy management platform responsible for actively managing the price and volume risks for the EDP Company�� portfolio in the Iberian Peninsula.

Renewable Energies

The Company�� electricity from renewable energies is generated by its subsidiary NEO, and in the United States of America by its subsidiary Horizon Wind Energy. In July 2007, EDP acquired 100% interest in Horizon, a developer, owner and operator of wind power generation in the United States, from the Goldman Sachs Group, Inc. In September 2007, Horizon owned 941 gross megawatt of operating wind projects and has 615 megawatt of projects under construction, for expected operational ! capacity of 1.556 gross megawatts (1.324 net megawatts).

Electricity Distribution

EDP develops the regulated electricity distribution activity in mainland Portugal and in Spain in the Asturias region and to a lower extent in Madrid, Valencia and Alicante. Electricity distribution activity is a regulated activity that consists in bringing the electricity, through the distribution network, from the transport network substations to the final consumption points. Within the scope of this activity, EDP builds, operates and maintains the distribution network and other installments aimed at electricity distribution, granting service quality and direct and customized assistance.

EDP Distribuicao Energia, S.A. is EDP�� company operating in the regulated distribution and supply businesses in Portugal. EDP�� distribution activity is regulated by energy service regulator (ERSE), which defines the tariffs, parameters and prices for electricity and other services in Portugal, controlling and assuring the levels of quality and service demanded by the Direccao Geral de Geologia e Energia (DGGE). EDP Distribuicao is holder of an open-ended binding license for the business of distribution of medium- and high-voltage electricity in mainland Portugal. It is also the concessionaire for almost all the low-voltage distribution network, in accordance with concession contracts with the municipalities. HC Energia operates in the regulated electricity distribution and supply business, with its natural market being the region of Asturias. HC Energia�� network covers the Asturias, Valencia, Madrid and Alicante regions.

Electricity Supply

EDP's electricity supply offers the services, such as maintenance and assistance services, services aimed at electricity quality, specialized technical services and energy efficiency services. EDP operates in Portugal through EDP Comercial, while in Spain, its electricity supply service is obtained from HC Energia or Naturgas, ! which off! ers its customers an integrated portfolio of gas and electricity products.

Gas

EDP has a presence in the gas sector in the Iberian Peninsula, through Naturgas in Spain, and through EDP Gas in Portugal. Naturgas market is the Basque Country, and Asturias, and it operates in the Spanish gas sector by providing services, such as transport, distribution and supply of gas; supply of gas in the liberalized market, and sourcing and trading.

Brazil Operations

EDP is present in Brazil through Energias do Brasil, a 62.4%-owned subsidiary. Energias do Brasil operates in the electricity generation, distribution and supply businesses.

Advisors' Opinion:
  • [By David Hunkar]

    Current Dividend Yield: 6.43%
    Sector: Telecom
    Country: Australia

    Company: Edp Energias De Portugal SA (EDPFY.PK)

    Current Dividend Yield: 4.68%
    Sector: Electric Utilities
    Country: Portugal

10 Best Safest Stocks To Watch Right Now: Boston Scientific Corp (BSX)

Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. During the year ended December 31, 2011, its products were offered for sale by seven core businesses: Interventional Cardiology, CRM, Endoscopy, Peripheral Interventions, Urology/Women�� Health, Neuromodulation, and Electrophysiology. In January 2011, it completed the acquisition of Intelect Medical, Inc. In January 2011, it completed the acquisition of Sadra Medical, Inc. In March 2011, the Company completed the acquisition of Atritech, Inc. In February 2011, it announced the acquisitions of S.I. Therapies and ReVascular Therapeutics, Inc. In January 2011, the Company sold its Neurovascular business to Stryker Corporation. In June 2012, the Company acquired Cameron Health, Inc. of San Clemente, California and, as a result, added to its product portfolio subcutaneous implantable cardioverter defibrillator, called the S-ICD System.

Interventional Cardiology

The Company offers coronary stent product. Coronary stents are tiny, mesh tubes used in the treatment of coronary artery disease, which are implanted in patients to prop open arteries and facilitate blood flow to and from the heart. The Company offers a two-drug platform strategy with its paclitaxel-eluting and everolimus-eluting stent system offerings, and it offers a range of stent sizes. The Company markets its next-generation internally-developed and self-manufactured PROMUS Element stent system in the United States, its Europe/Middle East/Africa (EMEA) region and certain Inter-Continental countries, including China and India. It markets the PROMUS everolimus-eluting stent system, supplied to the Company by Abbott Laboratories, in Japan. It also markets its TAXUS paclitaxel-eluting stent line, including its third-generation TAXUS Element paclitaxel-eluting stent system in the U.nited States, Japan, EMEA and certain Inter-Continental countries.

The Compa! ny markets a line of products used to treat patients with atherosclerosis, a principal cause of coronary artery obstructive disease. Its product offerings include balloon catheters, rotational atherectomy systems, guide wires, guide catheters, embolic protection devices, and diagnostic catheters used in percutaneous transluminal coronary angioplasty (PTCA). The Company markets a family of intraluminal catheter-directed ultrasound imaging catheters and systems for use in coronary arteries and heart chambers, as well as certain peripheral vessels. The iLab Ultrasound Imaging System continues as its flagship console and is compatible with its line of imaging catheters. The system is designed to enhance the diagnosis and treatment of blocked vessels and heart disorders. Sadra is developing a repositionable and retrievable device for transcatheter aortic valve replacement (TAVR) to treat patients with severe aortic stenosis. The Lotus Valve System consists of a stent-mounted tissue valve prosthesis and catheter delivery system for guidance and placement of the valve. Atritech has developed a device designed to close the left atrial appendage in patients with atrial fibrillation who are at risk for ischemic stroke. The WATCHMAN Left Atrial Appendage Closure Technology, developed by Atritech, is the first device proven in a randomized clinical trial to offer an alternative to anticoagulant drugs, and is approved for use in CE Mark countries.

Cardiac Rhythm Management

The Company develops, manufactures and markets a variety of implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, including Implantable cardioverter defibrillator (ICD) systems used to detect and treat abnormally fast heart rhythms (tachycardia) that could result in sudden cardiac death, including implantable cardiac resynchronization therapy defibrillator (CRT-D) systems used to treat heart failure, and implantable pacemaker systems used to manage slow or irregular heart rhyth! ms (brady! cardia), including implantable cardiac resynchronization therapy pacemaker (CRT-P) systems used to treat heart failure. Its product offerings include its COGNIS cardiac resynchronization therapy defibrillator (CRT-D), its TELIGEN ICD systems and its ALTRUA family of pacemaker systems. During 2011, it began the United States launch of its next-generation line of defibrillators, INCEPTA, ENERGEN and PUNCTUA.

Endoscopy

The Company markets a range of products to diagnose, treat and ease a variety of digestive diseases, including those affecting the esophagus, stomach, liver, pancreas, duodenum, and colon. Common disease states include esophagitis, portal hypertension, peptic ulcers as well as esophageal, biliary, pancreatic and colonic cancer. The Company offers the Radial Jaw 4 Single-Use Biopsy Forceps, which are designed to enable collection of large high-quality tissue specimens without the need to use large channel therapeutic endoscopes. Its exclusive line of RX Biliary System devices are designed to provide greater access and control for physicians to diagnose and treat challenging conditions of the bile ducts, such as removing gallstones, opening obstructed bile ducts and obtaining biopsies in suspected tumors. The Company also markets the Spyglass Direct Visualization System for direct imaging of the pancreatico-biliary system. The Spyglass System is a single-operator cholangioscopy device that offers clinicians a direct visualization of the pancreatico-biliary system and includes supporting devices for tissue acquisition, stone management and lithotripsy. Its products also include the WallFlex family of stents, in particular, the WallFlex Biliary line and WallFlex Esophageal line; and in 2011, the Company launched its Advanix Biliary Plastic Stent System and the Expect Endoscopic Ultrasound Aspiration Needle in the United States and certain international markets. Its Resolution Clip Device is an endoscopic mechanical clip designed to treat gastrointestinal bleeding.

T! he Company markets devices to diagnose, treat and ease pulmonary disease systems within the airway and lungs. Its products are designed to help perform biopsies, retrieve foreign bodies from the airway, open narrowings of an airway, stop internal bleeding, and ease symptoms of some types of airway cancers. Its product line includes pulmonary biopsy forceps, transbronchial aspiration needles, cytology brushes and tracheobronchial stents used to dilate narrowed airway passages or for tumor management. Asthmatx, Inc. designs, manufactures and markets a less-invasive, catheter-based bronchial thermoplasty procedure for the treatment of severe persistent asthma. The Alair Bronchial Thermoplasty System, developed by Asthmatx, has both CE Mark and Food and Drug Administration (FDA) approval and is the first device-based asthma treatment approved by the FDA.

Peripheral Interventions

The Company sells various products designed to treat patients with peripheral disease, including a line of medical devices used in percutaneous transluminal angioplasty and peripheral vascular stenting. Its peripheral product offerings include stents, balloon catheters, wires, peripheral embolization devices and vena cava filters. In 2010 and 2011, it launched several of its products internationally, including the EPIC self-expanding nitinol stent system in certain international markets, and the Carotid WALLSTENT stent system in Japan. The Company launched three new peripheral angioplasty balloons in 2011, including its next-generation Mustang percutaneous transluminal angioplasty (PTA) balloon, its Coyote balloon catheter, a highly deliverable and ultra-low profile balloon dilatation catheter designed for a range of peripheral angioplasty procedures and its Charger PTA Balloon Catheter, a 0.035 inch percutaneous transluminal angioplasty balloon catheter designed for post-stent dilatation, as well as conventional balloon angioplasty to open blocked peripheral arteries. The Company has commenced a limited ma! rket rele! ase of its OFFROAD re-entry catheter system in certain international markets, and in February 2012, it launched its TRUEPATH intraluminal CTO device in the United States.

The Company sells products designed to treat patients with non-vascular disease. Its non-vascular suite of products include biliary stents, drainage catheters and micro-puncture sets designed to treat, diagnose and ease various forms of benign and malignant tumors. The Company continues to market its extensive line of Interventional Oncology product solutions, including the Renegade HI-FLO Fathom microcatheter and guidewire system and Interlock - 35 Fibered IDC Occlusion System for peripheral embolization. The Company�� FilterWire EZ Embolic Protection System is a filter designed to capture embolic material that may become dislodged during a procedure, which could otherwise travel into the microvasculature where it could cause a heart attack or stroke. It is commercially available in the United States, its EMEA region and certain Inter-Continental countries for multiple indications, including the treatment of disease in peripheral, coronary and carotid vessels. It is also available in the United States for the treatment of saphenous vein grafts and carotid artery stenting procedures.

Urology/Women�� Health

The Company�� Urology/Women�� Health division develops, manufactures and sells devices to treat various urological and gynecological disorders. The Company sells a variety of products designed to treat patients with urinary stone disease, stress urinary incontinence, pelvic organ prolapse and excessive uterine bleeding. The Company offers a line of stone management products, including ureteral stents, wires, lithotripsy devices, stone retrieval devices, sheaths, balloons and catheters.

The Company markets a range of devices for the treatment of conditions, such as female urinary incontinence, pelvic floor reconstruction (rebuilding of the anatomy to its original state), and ! menorrhag! ia (excessive menstrual bleeding). It offers a breadth of mid-urethral sling products, sling materials, graft materials, pelvic floor reconstruction kits, and suturing devices. The Company markets its Genesys Hydro ThermAblator (HTA) system, a next-generation endometrial ablation system designed to ablate the endometrial lining of the uterus in premenopausal women with menorrhagia. The Genesys HTA System features a smaller and lighter console, simplified set-up requirements, and an enhanced graphic user interface and is designed to improve operating performance.

Neuromodulation

The Company within its Neuromodulation business markets the Precision Spinal Cord Stimulation (SCS) system, used for the management of chronic pain. In 2011, the Company launched its Clik Anchor for its Precision Plus SCS System, a rechargeable SCS device for chronic pain management. During 2011, it received FDA approval for and launched the Infinion 16 Percutaneous Lead, a 16-contact percutaneous lead. The Company also markets the Linear 3-4 and Linear 3-6 Percutaneous Leads for use with its SCS systems, which are designed to provide physicians more treatment options for their chronic pain patients. Intelect Medical, Inc. is a development-stage company developing advanced visualization and programming for the Vercise system.

Electrophysiology

The Company within its Electrophysiology business develops less-invasive medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart. Included in its product offerings are radio frequency (RF) generators, steerable RF ablation catheters, intracardiac ultrasound catheters, diagnostic catheters, delivery sheaths, and other accessories. Its products include the Blazer and Blazer Prime line of temperature ablation catheters, designed to deliver enhanced performance, responsiveness, and durability. Its cooled ablation portfolio includes the closed-loop irrigated catheter on the market, the Chilli II cooled! ablation! catheter, and the newly launched Blazer Open-Irrigated ablation catheter with a Total Tip Cooling Design.

The Company competes with Abbott Laboratories, Medtronic, Inc., St. Jude Medical, Inc. and Johnson & Johnson.

Advisors' Opinion:
  • [By Ben Levisohn]

    The S&P 500 gained 0.3% to 1,843.80 today as Boston Scientific (BSX), Dow Chemical (DOW) and Biogen Idec (BIIB) rose. The Dow Jones Industrial Average slid 0.3% to 16,414.44.

  • [By Alex Planes]

    Rounding out the S&P's double-digit gainers today is Boston Scientific (NYSE: BSX  ) , which gained 12.7% after impressing Wall Street with both its current progress and its forward projections. The device maker beat top- and bottom-line expectations for the second quarter, and that performance spurred management into raising its full-year guidance. Boston Scientific has nearly doubled since the start of the year, and this bounce was driven by the fact that the company finally posted operating revenue growth after a multiyear slide. RBC Capital Markets analyst Glenn Novarro was a bit shocked by that, noting that he couldn't recall the last time Boston Scientific posted organic revenue growth, and that "most on the Street did not anticipate positive revenue growth until later this year or in 2014." Can Boston Scientific keep it up? It will have to, to justify its stock gains over the past year.

  • [By Johanna Bennett]

    With its stock price already doubled in value over the last 12 months, is it time to back away from shares of Boston Scientific (BSX)? Cowen & Co. analyst Joshua Jennings doesn�� think so.

  • [By Dan Carroll and Max Macaluso, Ph.D.]

    In that time, a few key trends have stood out that investors should take note of ��particularly before Boston Scientific's (NYSE: BSX  ) earnings emerge this Thursday. Fool contributor Dan Carroll and health care analyst Max Macaluso discuss how the above companies fared this earnings season, and if the trends we've seen will come to shape Boston Scientific's earnings as well later this week.

No comments:

Post a Comment